Rita Rubin. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antiviral Agents/adverse effectsAntiviral Agents/therapeutic useCOVID-19/complicationsCOVID-19/diagnosisCOVID-19/drug therapyCOVID-19 TestingDrug CombinationsHumansLactams/adverse effectsLactams/therapeutic useLeucine/adverse effectsLeucine/therapeutic useNitriles/adverse effectsNitriles/therapeutic useProline/adverse effectsProline/therapeutic useRecurrenceRitonavir/adverse effectsRitonavir/therapeutic useViral Protease Inhibitors/adverse effectsViral Protease Inhibitors/therapeutic use
Substances: See more » Antiviral AgentsDrug CombinationsLactamsNitrilesViral Protease Inhibitorsnirmatrelvir and ritonavir drug combinationnirmatrelvirProlineLeucineRitonavir
Year: 2022 PMID: 35675094 DOI: 10.1001/jama.2022.9925
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272